Trial will inform choice between mAbs in severe asthma

Respiratory physicians in NSW are seeking research collaborators to take part in a head to head trial of mepolizumab and omalizumab in patients with severe allergic and eosinophilic asthma. Professor Peter Wark, a senior respiratory specialist at John Hunter Hospital and the University of Newcastle, is hoping to recruit 160 patient across Australia and New ...

Already a member?

Login to keep reading.

© 2021 the limbic